Antithrombotic therapy impact on intracranial hemorrhage in cerebrovascular cavernous malformations


  • There is no harmful association between antithrombotic therapy and intracranial hemorrhage (IH) or focal neurological deficit (FND) from cerebrovascular cavernous malformations (CCM) in adults.

Why this matters

  • The use of anticoagulants has been discouraged in patients with CCM.

  • Understanding the impact of antithrombotic therapy on IH and FND in CCM may lead to new treatment approaches.